Bretta Kittrell
Nurse Practitioner · Bamberg, SCNPI 1770090896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 508 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 508 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$706
- AstraZeneca$685
- Esperion Therapeutics, Inc.$494
- Novartis$456
- GSK$452
- plus $4K from 36 others
What the payments were for
- Food & beverage$8,028100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,028 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 158 | $167,179 |
| MounjaroTirzepatide | 93 | $110,786 |
| EliquisApixaban | 138 | $88,090 |
| JanuviaSitagliptin Phosphate | 99 | $78,513 |
| VraylarCariprazine Hcl | 45 | $69,002 |
| OtezlaApremilast | 12 | $67,882 |
| FarxigaDapagliflozin Propanediol | 77 | $63,475 |
| JardianceEmpagliflozin | 86 | $55,932 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 72 | $52,305 |
| LinzessLinaclotide | 53 | $44,549 |
| XareltoRivaroxaban | 28 | $23,139 |
| MyrbetriqMirabegron | 49 | $21,995 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 34 | $21,860 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 47 | $21,026 |
| TrulicityDulaglutide | 19 | $18,496 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $378 | $167,179158 claims |
| Lilly USA, LLCMounjaro, Trulicity | $706 | $129,282112 claims |
| AbbVieVraylar, Linzess, Qulipta | $1,114 | $125,980110 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $685 | $91,400129 claims |
| PfizerEliquis | $254 | $88,090138 claims |
| MerckJanuvia | $145 | $78,51399 claims |
| AmgenOtezla | $209 | $67,88212 claims |
| Boehringer IngelheimJardiance, Synjardy | $355 | $62,39197 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $452 | $58,06484 claims |
| Johnson & JohnsonXarelto | $20 | $23,13928 claims |
| Astellas Pharma US IncMyrbetriq | $55 | $21,99549 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $102 | $9,81112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Bamberg
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
- Gail KirbyGreer$18K
- Alissa StrojnyMyrtle Beach$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.